Adenosine Receptor Agonist

Adenosine Receptor Agonists (45):

Cat. No.	Product Name	Effect	Purity

HY-103173

5'-N-Ethylcarboxamidoadenosine	Agonist	99.86%
5'-N-Ethylcarboxamidoadenosine (NECA) is a nonselective adenosine receptor agonist.

HY-13201A

CGS 21680 Hydrochloride	Agonist	99.70%
CGS 21680 Hydrochloride is a selective adenosine A2A receptor agonist with a K_i of 27 nM.

HY-158179

A3AR agonist 3	Agonist
A3AR agonist 3 (Compound 15A) is a A3 adenosine receptor (A3AR) agonist, with K_i and EC₅₀ values of 2.27 and 0.20 nM for hA3 and cAMP, respectivelly. A3AR agonist 3 can e used for the research of neuroinflammation.

HY-103171

BAY 60-6583	Agonist	99.97%
BAY 60-6583 is a potent and high-affinity agonist of adenosine A_2B receptor (EC₅₀ = 3 nM) over A1, A2A, and A3 receptors. BAY 60-6583 binds to mouse, rabbit, and dog A2BAR with K_i values of 750 nM, 340 nM and 330 nM, respectively. BAY 60-6583 has a cardioprotective effect in a myocardial ischemia model.

HY-12365

Namodenoson	Agonist	99.75%
Namodenoson (CF-102) is a selective A3 adenosine receptor (A3AR) agonist (K_i=0.33 nM). Namodenoson displays 2500- and 1400-fold selectivity over A1 and A2A receptors respectively.

HY-13591

Piclidenoson	Agonist	99.28%
Piclidenoson (IB-MECA) is a first-in-class, orally active and selective A3 adenosine receptor (A3AR) agonist. Piclidenoson exhibits antiproliferative effect and induces apoptosis in different cancer cell types like melanoma, leukemia. Piclidenoson can be used for the research of autoimmune inflammatory diseases and COVID-19.

HY-A0168

Regadenoson	Agonist	99.59%
Regadenoson (CVT-3146) is a selective A2A adenosine receptor agonist and vasodilator that increases coronary blood flow, can be used in study of myocardial perfusion imaging. Regadenoson also increases the permeability of the blood-brain barrier (BBB) in rodents, can be used to study increased delivery of agents to the human CNS.

HY-103181

N6-Cyclopentyladenosine	Agonist	99.59%
N6-Cyclopentyladenosine (CPA) is a selective Adenosine A₁ receptor agonist, with K_i values of 2.3 nM, 790 nM and 43 nM for human A₁, A_2A and A₃ receptors, respectively.

HY-14917

Capadenoson	Agonist	99.62%
Capadenoson is a selective agonist of adenosine-A1 receptor.

HY-18939

N6-Cyclohexyladenosine	Agonist	99.98%
N6-Cyclohexyladenosine is a selective adenosine A1 receptor agonist (EC50 = 8.2 nM).

HY-18978

GR79236	Agonist	99.79%
GR79236 is a highly potent, selective and orally active adenosine A1 receptor agonist with a K_is of 3.1 nM and 1300 nM for A1 and A2 receptors, respectively. GR79236 has anti-nociceptive and anti-inflammatory actions.

HY-18776

A2AR-agonist-1	Agonist	99.05%
A2AR-agonist-1 is a potent A2AR and ENT1 agonist with Ki of 4.

HY-111809

N6-Ethyladenosine	Agonist	99.53%
N6-Ethyladenosine is an adenosine derivative, acts as a Adenosine receptor agonist, with K_is of 4.9 and 4.7 nM for hA₁AR and hA₃AR, respectively.

HY-18687

APNEA	Agonist	98.96%
APNEA (N6-[2-(4-Aminophenyl)ethyl]adenosine) is a potent, non-selective A3 adenosine receptor agonist.

HY-101854

N6-(2-Phenylethyl)adenosine	Agonist	99.41%
N6-(2-Phenylethyl)adenosine (N6-Phenethyladenosine), an adenosine derivative, is a potent adenosine receptors (AR) agonist with K_i values of 11.8 nM, 30.1 nM, 0.63 nM for rat A₁AR, human A₁AR and hA₃AR, respectively.

HY-106007

Trabodenoson	Agonist	99.97%
Trabodenoson (INO-8875), an adenosine mimetic, is a highly selective Adenosine A1 receptor agonist. Trabodenoson (INO-8875) is used in the study for Primary Open-Angle Glaucoma.

HY-N7844

N6-Benzyladenosine	Agonist	99.43%
N6-Benzyladenosine is an adenosine receptor agonist, has a cytoactive activity. N6-Benzyladenosine arrests cell cycle at G0/G1 phase and induces cell apoptosis. N6-Benzyladenosine also exerts inhibitory effect on T. gondii adenosine kinase and glioma^-.

HY-128064

Adenosine amine congener	Agonist	99.23%
Adenosine amine congener (ADAC) is a selective A1 adenosine receptor agonist, can ameliorate noise- and Cisplatin-induced cochlear injury. Adenosine amine congener also has neuroprotective effects.

HY-100032

PD 117519	Agonist	99.97%
PD 117519 (CI947) is an A_2A adenosine agonist which has shown oral antihypertensive activity in pharmacological animal models.

HY-N0586

Norisoboldine	Agonist	99.44%
Norisoboldine is an orally active natural aryl hydrocarbon receptor (AhR) agonist. Norisoboldine, as a major isoquinoline alkaloid present in Radix Linderae, can be used for the research of Rheumatoid arthritis and Ulcerative colitis.

Name
Email *

	Sorry, but the email address you supplied was invalid.